GSA Capital Partners’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,416
| Closed | -$63K | – | 1628 |
|
|
2024
Q1 | $63K | Buy |
+7,416
| New | +$63K | 0.01% | 1522 |
|
|
2021
Q4 | – | Sell |
-11,470
| Closed | -$568K | – | 1410 |
|
|
2021
Q3 | $568K | Buy |
11,470
+7,454
| +186% | +$369K | 0.06% | 629 |
|
|
2021
Q2 | $229K | Buy |
4,016
+2,326
| +138% | +$133K | 0.03% | 1117 |
|
|
2021
Q1 | $97K | Buy |
+1,690
| New | +$97K | 0.02% | 1003 |
|
|
2020
Q2 | – | Sell |
-833
| Closed | -$58K | – | 637 |
|
|
2020
Q1 | $58K | Buy |
+833
| New | +$58K | 0.01% | 947 |
|